Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 83

    1.

    New onset lymphopenia assessed during routine follow-up is a risk factor for relapse post-autologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma.

    Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN.

    Biol Blood Marrow Transplant. 2009 Oct 30. [Epub ahead of print]PMID: 19883776 [PubMed - as supplied by publisher]Related articles

    2.

    Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

    Holtan SG, Creedon DJ, Haluska P, Markovic SN.

    Mayo Clin Proc. 2009 Nov;84(11):985-1000. Review.PMID: 19880689 [PubMed - in process]Related articles

    3.

    B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.

    Wilcox RA, Feldman AL, Wada DA, Yang ZZ, Comfere NI, Dong H, Kwon ED, Novak AJ, Markovic SN, Pittelkow MR, Witzig TE, Ansell SM.

    Blood. 2009 Sep 3;114(10):2149-58. Epub 2009 Jul 13.PMID: 19597183 [PubMed - indexed for MEDLINE]Related articles

    4.

    The pathway ahead in melanoma trials.

    Miller AJ, Markovic SN, Haluska P Jr.

    Oncology (Williston Park). 2009 May;23(6):496, 498, 500. No abstract available. PMID: 19544690 [PubMed - indexed for MEDLINE]Related articles

    5.

    Novel therapeutics for the treatment of metastatic melanoma.

    Mansfield AS, Markovic SN.

    Future Oncol. 2009 May;5(4):543-57. Review.PMID: 19450181 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma.

    Nevala WK, Vachon CM, Leontovich AA, Scott CG, Thompson MA, Markovic SN; Melanoma Study Group of the Mayo Clinic Cancer Center.

    Clin Cancer Res. 2009 Mar 15;15(6):1931-9. Epub 2009 Feb 24.PMID: 19240164 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metastatic malignant melanoma.

    Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR; Melanoma Study Group of the Mayo Clinic Cancer Center.

    G Ital Dermatol Venereol. 2009 Feb;144(1):1-26. Review.PMID: 19218908 [PubMed - indexed for MEDLINE]Related articles

    8.

    Metastatic malignant melanoma manifesting as an intracardiac mass.

    Wood A, Markovic SN, Best PJ, Erickson LA.

    Cardiovasc Pathol. 2009 Feb 10. [Epub ahead of print]PMID: 19211272 [PubMed - as supplied by publisher]Related articles

    9.

    Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.

    Porrata LF, Ristow K, Habermann TM, Witzig TE, Inwards DJ, Markovic SN.

    Am J Hematol. 2009 Feb;84(2):93-7.PMID: 19123458 [PubMed - indexed for MEDLINE]Related articles

    10.

    Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.

    Perez DG, Suman VJ, Fitch TR, Amatruda T 3rd, Morton RF, Jilani SZ, Constantinou CL, Egner JR, Kottschade LA, Markovic SN.

    Cancer. 2009 Jan 1;115(1):119-27.PMID: 19090009 [PubMed - indexed for MEDLINE]Related articles

    11.

    A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study.

    Markovic SN, Suman VJ, Nevala WK, Geeraerts L, Creagan ET, Erickson LA, Rowland KM Jr, Morton RF, Horvath WL, Pittelkow MR.

    Am J Clin Oncol. 2008 Dec;31(6):573-9.PMID: 19060590 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Malignant melanoma in the 21st century: the emerging molecular landscape.

    Sekulic A, Haluska P Jr, Miller AJ, Genebriera De Lamo J, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic SN; Melanoma Study Group of Mayo Clinic Cancer Center.

    Mayo Clin Proc. 2008 Jul;83(7):825-46. Review.PMID: 18613999 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study.

    Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Gastineau DA, Litzow MR, Winters JL, Markovic SN.

    Biol Blood Marrow Transplant. 2008 Jul;14(7):807-16.PMID: 18541201 [PubMed - indexed for MEDLINE]Related articles

    14.

    mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD).

    Holtan SG, Porrata LF, Colgan JP, Zent CS, Habermann TM, Markovic SN.

    Am J Hematol. 2008 Aug;83(8):688-9. No abstract available. PMID: 18528858 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study.

    Ege H, Gertz MA, Markovic SN, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Porrata LF.

    Br J Haematol. 2008 Jun;141(6):792-8. Epub 2008 Apr 10.PMID: 18410454 [PubMed - indexed for MEDLINE]Related articles

    16.

    Emerging therapies for melanoma.

    Katipamula R, Markovic SN.

    Expert Rev Anticancer Ther. 2008 Apr;8(4):553-60. Review.PMID: 18402522 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.

    Palmer S, Hanson CA, Zent CS, Porrata LF, Laplant B, Geyer SM, Markovic SN, Call TG, Bowen DA, Jelinek DF, Kay NE, Shanafelt TD.

    Br J Haematol. 2008 May;141(5):607-14. Epub 2008 Apr 1.PMID: 18384436 [PubMed - indexed for MEDLINE]Related articles

    18.

    Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.

    Korn EL, Liu PY, Lee SJ, Chapman JA, Niedzwiecki D, Suman VJ, Moon J, Sondak VK, Atkins MB, Eisenhauer EA, Parulekar W, Markovic SN, Saxman S, Kirkwood JM.

    J Clin Oncol. 2008 Feb 1;26(4):527-34.PMID: 18235113 [PubMed - indexed for MEDLINE]Related articles

    19.

    A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma.

    Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN.

    Cancer. 2007 Oct 15;110(8):1791-5.PMID: 17721993 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.

    Simpson L, Ansell SM, Colgan JP, Habermann TM, Inwards DJ, Ristow KM, Johnston PB, Markovic SN, Micallef IN, Porrata LF, Witzig TE.

    Leuk Lymphoma. 2007 Jul;48(7):1332-7.PMID: 17613762 [PubMed - indexed for MEDLINE]Related articles

    21.

    Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.

    Porrata LF, Ristow K, Witzig TE, Tuinistra N, Habermann TM, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Markovic SN.

    Leukemia. 2007 Dec;21(12):2554-6. Epub 2007 Jun 21. No abstract available. PMID: 17581607 [PubMed - indexed for MEDLINE]Related articles

    22.

    A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.

    Markovic SN, Suman VJ, Rao RA, Ingle JN, Kaur JS, Erickson LA, Pitot HC, Croghan GA, McWilliams RR, Merchan J, Kottschade LA, Nevala WK, Uhl CB, Allred J, Creagan ET.

    Am J Clin Oncol. 2007 Jun;30(3):303-9.PMID: 17551310 [PubMed - indexed for MEDLINE]Related articles

    23.

    Demonstration of MPLW515K, but not JAK2V617F, in in vitro expanded CD4+ T lymphocytes.

    Pardanani A, Lasho TL, Finke C, Markovic SN, Tefferi A.

    Leukemia. 2007 Oct;21(10):2206-7. Epub 2007 May 17. No abstract available. PMID: 17507998 [PubMed - indexed for MEDLINE]Related articles

    24.

    Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.

    Behl D, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, Inwards DJ, White WL, Ansell SM, Micallef IN, Johnston PB, Porrata LF.

    Br J Haematol. 2007 Jun;137(5):409-15. Epub 2007 Apr 13.PMID: 17433025 [PubMed - indexed for MEDLINE]Related articles

    25.

    Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment.

    Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of Mayo Clinic Cancer Center.

    Mayo Clin Proc. 2007 Apr;82(4):490-513. Review.PMID: 17418079 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.

    Erickson LA, Jin L, Nakamura N, Bridges AG, Markovic SN, Lloyd RV.

    Cancer. 2007 May 15;109(10):1965-71.PMID: 17387744 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.

    Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of the Mayo Clinic Cancer Center.

    Mayo Clin Proc. 2007 Mar;82(3):364-80. Review.PMID: 17352373 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Tumor immunotherapy in melanoma: on the dawn of a new era?

    Wilcox R, Markovic SN.

    Curr Opin Mol Ther. 2007 Feb;9(1):70-8. Review.PMID: 17330404 [PubMed - indexed for MEDLINE]Related articles

    29.

    AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma.

    Holtan SG, Porrata LF, Micallef IN, Padley DJ, Inwards DJ, Ansell SA, Johnston PB, Gastineau DA, Markovic SN.

    Clin Lymphoma Myeloma. 2007 Jan;7(4):315-8.PMID: 17324341 [PubMed - indexed for MEDLINE]Related articles

    30.

    The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.

    Micallef IN, Remstein ED, Ansell SM, Colgan JP, Inwards DJ, Johnston PB, Lewis JT, Markovic SN, Porrata LF, White WL, Witzig TE, Ristow K, Habermann TM.

    Leuk Lymphoma. 2006 Sep;47(9):1794-9.PMID: 17064990 [PubMed - indexed for MEDLINE]Related articles

    31.

    Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma.

    Markovic SN, Dietz AB, Greiner CW, Maas ML, Butler GW, Padley DJ, Bulur PA, Allred JB, Creagan ET, Ingle JN, Gastineau DA, Vuk-Pavlovic S.

    J Transl Med. 2006 Aug 15;4:35.PMID: 16911798 [PubMed]Related articlesFree article

    32.

    A reproducible method for the enumeration of functional (cytokine producing) versus non-functional peptide-specific cytotoxic T lymphocytes in human peripheral blood.

    Markovic SN, Nevala WK, Uhl CB, Celis E, McKean DJ.

    Clin Exp Immunol. 2006 Sep;145(3):438-47.PMID: 16907911 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.

    Markovic SN, Suman VJ, Ingle JN, Kaur JS, Pitot HC, Loprinzi CL, Rao RD, Creagan ET, Pittelkow MR, Allred JB, Nevala WK, Celis E.

    Am J Clin Oncol. 2006 Aug;29(4):352-60.PMID: 16891861 [PubMed - indexed for MEDLINE]Related articles

    34.

    Absolute lymphocyte count predicts overall survival in follicular lymphomas.

    Siddiqui M, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, Inwards DJ, White WL, Ansell SM, Micallef IN, Johnston PB, Call TG, Porrata LF.

    Br J Haematol. 2006 Sep;134(6):596-601. Epub 2006 Aug 1.PMID: 16889618 [PubMed - indexed for MEDLINE]Related articles

    35.

    Androgenic therapy for Waldenstrom's macroglobulinemia.

    Porrata LF, Markovic SN.

    Am J Hematol. 2006 Nov;81(11):892-3. No abstract available. PMID: 16783787 [PubMed - indexed for MEDLINE]Related articles

    36.

    A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy.

    Halfdanarson TR, Markovic SN, Kalokhe U, Luppi M.

    Ann Oncol. 2006 Dec;17(12):1849-50. Epub 2006 Jun 9. No abstract available. PMID: 16766593 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion.

    Daniels CE, Myers JL, Utz JP, Markovic SN, Ryu JH.

    Respir Med. 2007 Jan;101(1):162-8. Epub 2006 May 15.PMID: 16704928 [PubMed - indexed for MEDLINE]Related articles

    38.

    Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.

    Holtan SG, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Litzow MR, Gastineau DA, Markovic SN.

    Br J Haematol. 2006 Jun;133(6):628-33.PMID: 16704437 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target.

    Katipamula R, Porrata LF, Gastineau DA, Markovic SN, Moore SB, Greiner C, Burgstaler EA, Padley DJ, Winters JL.

    Bone Marrow Transplant. 2006 May;37(9):811-7.PMID: 16532018 [PubMed - indexed for MEDLINE]Related articles

    40.

    Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.

    Joao C, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Gastineau DA, Markovic SN.

    Bone Marrow Transplant. 2006 May;37(9):865-71.PMID: 16532015 [PubMed - indexed for MEDLINE]Related articles

    41.

    Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.

    Rao RD, Holtan SG, Ingle JN, Croghan GA, Kottschade LA, Creagan ET, Kaur JS, Pitot HC, Markovic SN.

    Cancer. 2006 Jan 15;106(2):375-82.PMID: 16342250 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.

    Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, Litzow MR.

    Leukemia. 2006 Jan;20(1):29-34.PMID: 16281063 [PubMed - indexed for MEDLINE]Related articles

    43.

    The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.

    Yoong Y, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Litzow MR, Gertz MA, Lacy MQ, Dispenzieri A, Gastineau DA, Tefferi A, Elliott M, Snow DS, Hogan WJ, Markovic SN.

    Leuk Lymphoma. 2005 Sep;46(9):1287-94.PMID: 16109605 [PubMed - indexed for MEDLINE]Related articles

    44.

    A phase II study of bortezomib in the treatment of metastatic malignant melanoma.

    Markovic SN, Geyer SM, Dawkins F, Sharfman W, Albertini M, Maples W, Fracasso PM, Fitch T, Lorusso P, Adjei AA, Erlichman C.

    Cancer. 2005 Jun 15;103(12):2584-9.PMID: 15887220 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.

    Porrata LF, Gertz MA, Litzow MR, Lacy MQ, Dispenzieri A, Inwards DJ, Ansell SM, Micallef IN, Gastineau DA, Elliott M, Hogan WJ, Hayman SR, Tefferi A, Markovic SN.

    Clin Cancer Res. 2005 Feb 1;11(3):1210-8.PMID: 15709191 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation.

    Porrata LF, Markovic SN.

    Clin Exp Med. 2004 Oct;4(2):78-85. Review.PMID: 15672944 [PubMed - indexed for MEDLINE]Related articles

    47.

    Malignant basomelanocytic tumor manifesting as metastatic melanoma.

    Erickson LA, Myers JL, Mihm MC, Markovic SN, Pittelkow MR.

    Am J Surg Pathol. 2004 Oct;28(10):1393-6.PMID: 15371958 [PubMed - indexed for MEDLINE]Related articles

    48.

    Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.

    Shehan JM, Kalaaji AN, Markovic SN, Ahmed I.

    J Am Acad Dermatol. 2004 Jul;51(1):103-10. Review.PMID: 15243534 [PubMed - indexed for MEDLINE]Related articles

    49.

    Clopidogrel-associated autoimmune thrombocytopenic purpura.

    Best PJ, Mathew V, Markovic SN.

    Catheter Cardiovasc Interv. 2004 Jul;62(3):339-40.PMID: 15224300 [PubMed - indexed for MEDLINE]Related articles

    50.

    The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma.

    Porrata LF, Gertz MA, Geyer SM, Litzow MR, Gastineau DA, Moore SB, Pineda AA, Bundy KL, Padley DJ, Persky D, Lacy MQ, Dispenzieri A, Snow DS, Markovic SN.

    Leukemia. 2004 Jun;18(6):1085-92.PMID: 15042106 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...